Abstract:Aims: Hydroxychloroquine (HCQ) has a high variability and a long half-life in the human body. The purpose of this study was to evaluate the bioequivalence of a generic HCQ tablet (test preparation) versus a brand HCQ tablet (reference preparation) under fasting and fed conditions in a crossover design. Materials and methods: This was an open-label, two-period randomized, single-dose, crossover study in 47 healthy Chinese subjects who were sequentially and randomly allocated either to the fed group (high-fat meal; n = 23) or the fasting group (n = 24). Participants in each group were randomized to the two arms to receive either a single 200-mg dose of the test preparation or a 200-mg dose of the reference preparation. The application of the two preparations in each patient was separated by a 28-day washout period, regarded as sufficiently long to avoid significant interference from residual drug in the body. Whole blood samples were collected over 72 hours after drug administration. Results: A total of 23 subjects completed both the fed and the fasting parts of the trial. There were no significant differences in Cmax, AUC0-72h, and T1/2 between the test and reference preparation (p < 0.05). Food had no significant effect on Cmax and T1/2 (p < 0.05), but AUC0-72h values were significantly reduced under fed condition compared to fasting condition (p < 0.05). The 90% confidence intervals (CIs) for the geometric mean ratios (GMRs) of Cmax and AUC0-72h were 0.84 - 1.05 and 0.89 - 0.98 in the fed study, and 0.97 - 1.07 and 0.97 - 1.05 in the fasting study, respectively. The carryover effect due to non-zero blood concentrations resulted in higher AUC0-72h values in the second period for both test and reference formulations and had no effect on the statistical results. No serious adverse events were reported. Conclusion: The investigation demonstrated that the test and reference preparations are bioequivalent and well tolerated under both fasting and fed conditions in healthy Chinese subjects.

Study on Bioequivalence of Ciclosporin Microemulsion Oral Solution in Healthy Volunteers

Study on bioequivalence of cilostazol table in healthy volunteers

Measurement of ciclosporin in whole blood by HPLC

Bioequivalence of Lansoprazole Enteric Caspsules in Healthy Volunteers

Bioequivalence of Clarithromycin Dispersed Tablet in Health Volunteers

Bioeguivalent Study of Two Fluconazole Capsules in Human Plasma

Bioequivalent Study of Citalopram Tablets

Equivalence of cyclosporine blood level assays in patients receiving cyclosporine microemulsion or cyclosporine

[Pharmacokinetics and Relative Bioavailability of Ziprasidone Tablets in Chinese Healthy Volunteers].

Bioavailability of Cefuroxime Axetii Suspension in Healthy Volunteers

Comparison of peak and trough level monitoring of cyclosporine treatment using two modern cyclosporine preparations

Relative bioavailability of cefpodoxime proxetil tablets in healthy volunteers

Bioequivalence of erythromycin enteric-coated capsules in healthy volunteers

Evaluation of the bioequivalence and pharmacokinetics of two formulations of secnidazole after single oral administration in healthy volunteers

A crossover study to evaluate the pharmacokinetics and bioequivalence of hydroxychloroquine tablets in healthy Chinese subjects

Bioequivalence of Azithromycin Tablets in Healthy Volunteers

Study on Steady-State Pharmacokinetics of Ciclosporin in Henmtopoietic Stem Cell TransPlantation Recipients

Bioequivalence of Domestic Azithromycin Granules in Healthy Volunteers

Pharmacokinetics and Bioequivalance of Ambroxol Dispersible Tablets in Healthy Volunteers

Bioequivalence of Glipizide Controlled-Release Tablets in Chinese Healthy Volunteers

Pharmacokinetics and bioequivalence of roxithromycin capsules in healthy volunteers